
X
Sanofi invests in new Canadian vaccine manufacturing plant
https://pharmaphorum.com/news/sanofi-invests-new-canadian-vaccine-manufacturing-plant/
Regeneron dumps suptavumab after phase 3 trial failure.
But sales of key insulin fall amid biosimilar competition.
Costly accounting error for Sanofi.